ArticleBiomarker research2018

NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.

Michelle X Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.